Patents

US 8551475 B2: Methods of reducing transplant rejection and cardiac allograft vasculopathy by implanting autologous stem cells

Granted
2013-10-08
Filed
2012-02-27 application 13406449
Type
Utility · 12 claims
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

The invention provides novel methods of reducing transplant rejection and cardiac allograft vasculopathy in humans by employing the implantation of autologous progenitor cells into the transplanted donor heart. The autologous progenitor cells can be vascular progenitor cells (VPCs) and/or myocyte progenitor cells (MPCs) isolated from the recipient's explanted heart. Alternatively, bone marrow progenitor cells (BMPCs) isolated from the recipient may also be used.

Source: PVGPATDIS, file of 2026-04-10 (ipg131008.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
NEW YORK MEDICAL COLLEGE 19 patentsUS company or organizationValhalla, NYNew York Medical College College or university EXACT high confidence: identical full name and state
NEW YORK MEDICAL COLLEGE Nonprofit EXACT high confidence: identical full name and state
PVGPATDIS, file of 2026-04-10

Inventors

InventorPlacePatentsPerson pageSource
Piero AnversaBoston, MA17PVGPATDIS, file of 2026-04-10
Annarosa LeriBoston, MA11PVGPATDIS, file of 2026-04-10
Jan KajsturaBoston, MA8PVGPATDIS, file of 2026-04-10

CPC categories

SubclassCategoryFirst groupSource
C12NMicroorganisms or enzymes; compositions thereof; propagating, preserving, or maintaining microorganisms; mutation or genetic engineering; culture mediaC12N5/0659PVGPATDIS, file of 2026-04-10
A61KPreparations for medical, dental or toiletry purposesA61K39/001PVGPATDIS, file of 2026-04-10
A61PSpecific therapeutic activity of chemical compounds or medicinal preparationsA61P9/00PVGPATDIS, file of 2026-04-10

Cooperative Patent Classification, as currently assigned (one row per subclass).

Assignments and security interests

RecordedWhatFromToReel/frameSource
2012-04-25Assignment
Assignment of assignor's interest
ANVERSA, DR. PIERO signed 2009-01-20
KAJSTURA, DR. JAN signed 2009-01-20
LERI, DR. ANNAROSA signed 2009-01-20
NEW YORK MEDICAL COLLEGE VALHALLA, NY28106/456ECORSEXC, file of 2026-09-25
2012-03-02Assignment
Assignment of assignor's interest
ANVERSA, PIERO signed 2009-01-20
KAJSTURA, JAN signed 2009-01-20
LERI, ANNAROSA signed 2009-01-20
NEW YORK MEDICAL COLLEGE VALHALLA, NY27796/896ECORSEXC, file of 2026-09-25

Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.